This issue focuses (explores strategies to improve) on improving cystic fibrosis (CF) detection across the lifespan, highlighting national consensus guidance for newborn screening program design and strategies to reduce racial and ethnic disparities in CF diagnosis. It also underscores the need for expanded CFTR variant panels, safety net newborn screening approaches, and vigilant recognition of CF in adults with certain clinical features.
Describe emerging newborn screening approaches and expanded CFTR variant panels that enhance early detection of CF across diverse populations.
Identify the clinical features and diagnostic strategies for recognizing cystic fibrosis in adults, including atypical and late-diagnosed cases, to ensure diagnosis and appropriate treatment.
Assistant Professor of Pediatrics
Johns Hopkins University School of Medicine
Baltimore, MD
Menowitz/Rosenstein Professor of Pediatric Respiratory Sciences
Director, Eudowood Division of Pediatric Respiratory Sciences
Director, Cystic Fibrosis Center
Johns Hopkins School of Medicine
Baltimore, MD
Menowitz/Rosenstein Professor of Pediatric Respiratory Sciences
Director, Eudowood Division of Pediatric Respiratory Sciences
Director, Cystic Fibrosis Center
Johns Hopkins School of Medicine
Baltimore, MD
Senior Clinical Nurse/Case Manager
Pediatric CF Program Coordinator
Johns Hopkins Cystic Fibrosis Center
Baltimore, MD
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: September 1, 2026
Expiration date: August 31, 2028